Lalistat 1

CAS No. 501104-16-1

Lalistat 1( ZINC795230 )

Catalog No. M28175 CAS No. 501104-16-1

Lalistat 1 is an inhibitor of lysosomal acid lipase (LAL, IC50 = 68 nM) and IgA1 protease for H. influenzae.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 44 In Stock
10MG 60 In Stock
25MG 93 In Stock
50MG 138 In Stock
100MG 202 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Lalistat 1
  • Note
    Research use only, not for human use.
  • Brief Description
    Lalistat 1 is an inhibitor of lysosomal acid lipase (LAL, IC50 = 68 nM) and IgA1 protease for H. influenzae.
  • Description
    Lalistat 1 is an inhibitor of lysosomal acid lipase (LAL, IC50 = 68 nM) and IgA1 protease for H. influenzae. Lalistat 1 can be used in studies about niemann-pick type C diseases.(In Vitro):Lalistat 1 (0-100 μM) dose-dependently inhibits IgA1P B1 and B2, almost completely at 50 μM and completely at 100 μM .Lalistat 1 reduces cholesterol accumulation in lysosome-like reservoirs of GM03123 human fibroblasts lacking NPC1 .
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ZINC795230
  • Pathway
    GPCR/G Protein
  • Target
    Antibacterial
  • Recptor
    MMP-12
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    501104-16-1
  • Formula Weight
    298.36
  • Molecular Formula
    C12H18N4O3S
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 20 mg/mL (67.03 mM)
  • SMILES
    O=C(Oc1nsnc1N1CCCCC1)N1CCOCC1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Morales R, et al. Crystal structures of novel non-peptidic, non-zinc chelating inhibitors bound to MMP-12. J Mol Biol. 2004 Aug 20;341(4):1063-76.
molnova catalog
related products
  • Sultamicillin

    Sultamicillin is an orally active double prodrug of Ampicillin/Sulbactan. Sulbactam is a semisynthetic β-Lactamase inhibitor.

  • GSK2556286

    GSK2556286 (GSK286) is an orally active inhibitor of Mycobacterium tuberculosis (M. tuberculosis), effective against multidrug-resistant (MDR), extensively drug-resistant (XDR), and drug-sensitive (DS) strains.

  • Nacubactam

    Nacubactam is a potent inhibitor of non-β-lactam-β-lactamase with activity against class A and class C β-lactamases.